For an asymptomatic hypertensive patient with unknown home antihypertensive regimen, normal renal function, no diabetes, and a blood pressure around 170/90 mm Hg, is starting amlodipine 5 mg orally daily appropriate or should an alternative regimen be used?

Amlodipine 5 mg Daily is Appropriate for This Patient

Starting amlodipine 5 mg orally once daily is an appropriate and guideline-concordant choice for this patient with Grade 1 hypertension (BP 170/90 mm Hg), known hypertension history, and no contraindications. 1, 2

Rationale Based on Current Guidelines

Your patient has Grade 1 hypertension (140-159/90-99 mm Hg) with a BP of 170/90 mm Hg. According to the 2020 International Society of Hypertension guidelines, this patient requires immediate drug treatment because they have a reported history of hypertension, which places them in a higher-risk category 1.

Drug Selection Algorithm

For non-Black patients with Grade 1 hypertension, the ISH 2020 guidelines recommend the following stepwise approach 1:

1. First-line: Low-dose ACE inhibitor/ARB OR dihydropyridine calcium channel blocker (DHP-CCB)
2. If inadequate response: Increase to full dose
3. Then add thiazide/thiazide-like diuretic
4. Then add spironolactone or alternatives

Amlodipine (a DHP-CCB) is explicitly listed as a first-line option and is appropriate as initial monotherapy in this scenario 1.

Why Amlodipine 5 mg is the Right Starting Dose

The FDA-approved dosing for amlodipine specifies that 5 mg once daily is the usual initial antihypertensive dose, with a maximum of 10 mg daily 2. The 5 mg starting dose is particularly appropriate because:

• It provides effective BP reduction (mean reductions of 20-23/14-17 mm Hg in clinical trials) 3, 4
• It maintains 24-hour BP control with once-daily dosing 5, 6
• It has a favorable safety profile at this dose 7, 3
• Titration to 10 mg can occur after 7-14 days if BP goals are not met 2

Advantages of Amlodipine in This Clinical Context

Given the unknown home medication regimen, amlodipine offers specific advantages:

• Long half-life (35-50 hours) provides continuous BP protection even if doses are missed, which is relevant given the uncertain medication history 8
• Gradual onset of action minimizes risk of precipitous BP drops 2
• No renal dose adjustment needed with normal renal function 2
• Proven cardiovascular protection beyond BP lowering 8
• Well-tolerated with predictable side effect profile (peripheral edema being most common) 7, 3

Important Clinical Considerations

Monitoring Plan

• Target BP: <140/90 mm Hg initially (ISH 2020 recommends <130/80 mm Hg as optimal target) 1
• Achieve target within 3 months 1
• Reassess BP in 7-14 days, though more rapid titration is acceptable with frequent assessment 2
• If BP remains ≥140/90 mm Hg on amlodipine 5 mg after 2-4 weeks, increase to 10 mg daily 2

When to Consider Alternative or Combination Therapy

If BP control is inadequate on amlodipine 10 mg after 4-6 weeks:

• Add a thiazide-like diuretic (chlorthalidone or indapamide preferred) 1
• Or add an ACE inhibitor/ARB 1

Recent evidence suggests that combination therapy (amlodipine + ARB) may achieve BP control more effectively than monotherapy (2.25 times higher odds of BP control), though with comparable safety 9. However, starting with monotherapy remains guideline-concordant for Grade 1 hypertension without high-risk features 1.

Common Pitfalls to Avoid

1. Don't start with 2.5 mg unless the patient is elderly (>80 years), frail, or has hepatic insufficiency—none of which apply here 2
2. Don't delay treatment waiting to verify home medications—this patient has persistent BP elevation and requires immediate therapy 1
3. Don't overlook lifestyle interventions—these should be initiated concurrently 1
4. Monitor for peripheral edema (most common side effect), which occurs more frequently at 10 mg dose 8
5. Ensure 24-hour BP coverage—amlodipine's long half-life makes it ideal for once-daily dosing 5, 6, 8

Side Effect Profile

Expected side effects include 2, 8:

• Peripheral edema (dose-dependent, more common at 10 mg)
• Dizziness
• Flushing
• Palpitations

These are generally mild to moderate and do not typically require discontinuation 3, 4.

Alternative Consideration

If the patient's race is Black, the ISH 2020 guidelines recommend starting with either:

• Low-dose ARB + DHP-CCB combination, OR
• DHP-CCB + thiazide-like diuretic 1

In this case, amlodipine monotherapy would still be acceptable, but combination therapy might be preferred 1.

Your plan to start amlodipine 5 mg daily with continued BP monitoring is evidence-based, guideline-concordant, and clinically appropriate for this patient.